CARNACULIN

This brand name is authorized in Japan

Active ingredients

The drug CARNACULIN contains one active pharmaceutical ingredient (API):

1 Kallidinogenase UNII OT9M1PSK9N - KALLIDINOGENASE
Read about Kallidinogenase

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C04AF01	Kallidinogenase	C Cardiovascular system → C04 Peripheral vasodilators → C04A Peripheral vasodilators → C04AF Enzymes
Discover more medicines within C04AF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: JP	医薬品医療機器総合機構	Identifier(s): 2491001F5056, 2491001F6060, 2491001M3044

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.